S. Ciccotto

Phase I T rial o f M ultiple C ycles o f H igh-Dose C arboplatin, Paclitaxel, a nd T opotecan W ith P eripheral-Blood S tem- Cell S upport a s F ront-Line T herapy

M. Millenson, R. Ozols, L. Weiner, 2001 .

Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapy.

M. Millenson, R. Ozols, L. Weiner, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SPECIES DIFFERENCES IN METABOLISM AND PHARMACOKINETICS OF A SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST IN RATS AND DOGS: FORMATION OF A UNIQUE GLUTATHIONE ADDUCT IN THE RAT

Y. Teffera, Wei Tang, G. Doss, 2006, Drug Metabolism and Disposition.

Disposition of the Dipeptidyl Peptidase 4 Inhibitor Sitagliptin in Rats and Dogs

David Q. Liu, S. Xu, M. Beconi, 2007, Drug Metabolism and Disposition.

Effect of the anticoagulant ethylenediamine tetra-acetic acid (EDTA) on the estimation of pharmacokinetic parameters: A case study with tigecycline and ciprofloxacin

K. A. Ramsay, K. Ramsay, Q. Chen, 2008, Xenobiotica; the fate of foreign compounds in biological systems.

Distribution of Small Magnetic Particles in Brain Tumor-bearing Rats

J. Gallo, S. Pulfer, S. Ciccotto, 2004, Journal of Neuro-Oncology.

Induction of hepatic phase II drug-metabolizing enzymes by 1,7-phenanthroline in rats is accompanied by induction of MRP3.

Mi-Sook Kim, R. Franklin, D. Hartley, 2003, Drug metabolism and disposition: the biological fate of chemicals.